The effect of oral versus intravenous fluid therapy on maternal and neonatal outcomes for women with oligohydramnios

Ali, Hala A; Ahmed, Sabah Ramadan Hussein

doi:10.4103/enj.enj_43_17

Cited by 3 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It would, however, be even more important for women carrying pregnancies at risk of uteroplacental insufficiencies because poor fluid intake could lead to additional fetal impairment. Several studies also demonstrated the importance of maintaining appropriate hydration during exercise, temperature exposure, or gastrointestinal loss during pregnancy [ 11 ]. Oligohydramnios can also be due to changes in water channels (aquaporin 1 and 2) in the membranes of the embryo and placenta [ 12 ].…”

Section: Introductionmentioning

confidence: 99%

Efficacy of inhaled Desmopressin in pregnant women with idiopathic oligohydramnios – a randomized controlled trial

et al. 2022

View full text Add to dashboard Cite

The aim of this study was to investigate the therapeutic effect of inhaled Desmopressin (DDAVP) in pregnant women with idiopathic oligohydramnios. This randomized, double-blind clinical trial involved 44 pregnant women at 28–37 weeks of gestation with idiopathic oligohydramnios admitted in 2 academic hospitals in Mashhad, Iran, from 2018 to 2019. In the intervention group, 10µg DDAVP was nasally sprayed. The control group received intravenous maintenance fluid. The hematocrit, electrolytes, blood pressure and urine-specific gravity were evaluated at baseline and 3, 8, and 24 hours later. Amniotic fluid index (AFI) was measured using ultrasound at baseline, 24 and 48 hours later. There was no significant difference in the basic characteristics (age, body mass index, and gestational age) between the two groups. The pattern of changes of AFI (baseline, 24 and 48 hours later) increased in the intervention (4.16±0.86, 7.08±1.453 and 7.76±1.62, p<0.001) and control groups (4.23±0.70, 5.39±1.079 and 5.68±1.10, p<0.001). Serum sodium levels significantly declined in the intervention group (p<0.001) but not in the control group (p=0.07). There were no significant differences in potassium (p=0.89), hematocrit (p=0.23), systolic blood pressure (p=0.21) and diastolic blood pressure (p=0.97). However, urine-specific gravity had an increasing pattern in the intervention group (p<0.001) and a decreasing pattern in the control group (p<0.001). This study showed that Desmopressin inhalation could increase the AFI and urine specific gravity, enhancing oligohydramnios treatment in pregnant women, compared to serum administration.

show abstract

Section: Introductionmentioning

confidence: 99%

Efficacy of inhaled Desmopressin in pregnant women with idiopathic oligohydramnios – a randomized controlled trial

et al. 2022

View full text Add to dashboard Cite

show abstract

“…1 There are multiple causes of oligohydramnios like rupture membranes, hypertension, fetal urinary tract abnormalities, drugs or can be identified without any cause described above when it is called isolated oligohydramnios. 2 Oligohydramnios is also observed in post term pregnancies and occurs in 12% pregnancies after 41 weeks of gestation. 3 Oligohydramnios is invariably associated with increased rate of perinatal morbidity and mortality as a result of cord compression, fetal distress, pulmonary hypoplasia.…”

Section: Introductionmentioning

confidence: 99%

Oral versus intravenous maternal hydration in isolated third trimester oligohydramnios

Zafar¹,

Naz²,

Fatima³

et al. 2020

Int J Res Med Sci

View full text Add to dashboard Cite

Background: To study the effect of oral and intravenous maternal hydration in patients with isolated oligohydramnios in terms of mean change in amniotic fluid.Methods: A total number of 38 patients included in the study which fulfill the selection criteria. Patients were randomly divided in two groups. Amniotic fluid index (AFI) of all patients was measured before the hydration therapy according to the method of Phelan et al. In maternal oral hydration (Group A), every patient was instructed to drink two liters of water over two hours daily for 1 week. In intravenous hydration (Group B), every woman infused two liters of 0.9% normal saline in two hour daily for 1 week. After 48 hours and 1 week of oral and intravenous hydration, the AFI was reassessed by the same observer. Patients were monitored closely for sign and symptoms of fluid overload. Data was stratified for mean difference in improvement in amniotic fluid index.Results: After oral hydration therapy AFI was 5.926±0.4593 after 48 hours and 8.286±0.6000 after 7 days in Group A. In Group B AFI was 5.784±0.4622 after 48 hours and 7.868±0.2810 after 7 days of intravenous hydration. P value after 48 hours is 0.348 and p=0.014 after 7 days means oral hydration therapy significantly increase amniotic fluid index.Conclusions: Oral maternal hydration significantly increase the amniotic fluid index in patients with isolated oligohydramnios. It is simple, safe and non-invasive method.

show abstract

Acute Oral Hydration in Management of Oligohydramnios and Doppler Changes

Farghal

Zakaria

Sedek

2021

Al-Azhar Medical Journal

View full text Add to dashboard Cite

The effect of oral versus intravenous fluid therapy on maternal and neonatal outcomes for women with oligohydramnios

Cited by 3 publications

References 0 publications

Efficacy of inhaled Desmopressin in pregnant women with idiopathic oligohydramnios – a randomized controlled trial

Efficacy of inhaled Desmopressin in pregnant women with idiopathic oligohydramnios – a randomized controlled trial

Oral versus intravenous maternal hydration in isolated third trimester oligohydramnios

Acute Oral Hydration in Management of Oligohydramnios and Doppler Changes

Contact Info

Product

Resources

About